HBM Healthcare Investments (Cayman) Ltd. - 31 Dec 2024 SCHEDULE 13G/A Report for Benitec Biopharma Inc. Common Stock, par value $0.0001 per share (BNTC)

Filing Manager: HBM Healthcare Investments (Cayman) Ltd.
Reporting Manager: HBM Healthcare Investments (Cayman) Ltd.
Security: Benitec Biopharma Inc. Common Stock, par value $0.0001 per share
Symbol: BNTC
Shares outstanding: 23,148,200 shares
Disclosed Ownership: 1,041,669 shares
Ownership: 4.5%
Form type: SCHEDULE 13G/A
Filing time: 13 Feb 2025, 16:15:16 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
HBM Healthcare Investments (Cayman) Ltd.	4.5%	1,041,669	1,041,669	0	/s/ Jean-Marc LeSieur	Jean-Marc LeSieur, Managing Director